Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 71.2% to $0.2243 in pre-market trading after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Versus Systems Inc. (NASDAQ: VS) rose 28% to $1.00 in pre-market trading after gaining around 7% on Tuesday. Versus Systems recently announced pricing of a $2.1 million public offering.
Senti Biosciences, Inc. (NASDAQ: SNTI) rose 17.4% to $1.69 in pre-market trading after dipping more than 21% on Tuesday.
Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 15.8% to $0.2839 in pre-market trading.
Clovis Oncology, Inc. (NASDAQ: CLVS) rose 12.8% to $0.1503 in pre-market trading after dropping 34% on Tuesday. Clovis Oncology voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.
BIMI International Medical, Inc. (NASDAQ: BIMI) rose 12.8% to $2.35 in pre-market trading. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd.
Cuentas Inc. (NASDAQ: CUEN) rose 12.2% to $0.3090 in pre-market trading after gaining 8% on Tuesday.
Root, Inc. (NASDAQ: ROOT) rose 11.9% to $5.91 in pre-market trading. ...
Related tickers: ROOT, YI, CUEN, RBCN, HAPP, GAME, CRKN, CJJD, CLVS, KSPN, IVDA, AMST, SNTI, NCPL, BIMI, PBLA, DS, SCPS, HTGM, YMTX, OPGN, VLON, MCRB, LVTX, IQ, DDL, OBSV, REBN, VS.
Read Full Article
